Lung Non-Small Cell Carcinoma Clinical Trials in Washington, Illinois

5 studies are recruiting for lung non-small cell carcinoma in Washington, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

   This phase III trial compares the effect of atezolizumab (or atezolizumab and recombinant human hyaluronidase) to standard observation for preventing cancer return after surgery (recurrence) in patients who have undergone a complete surgical removal (resection) of stage I non-small cell lung cancer…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Illinois CancerCare - Washington, Washington, Illinois

   Locations

   70 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT07388524 on ClinicalTrials.gov

2. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

   This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immu…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Illinois CancerCare - Washington, Washington, Illinois

   Locations

   1151 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT04267848 on ClinicalTrials.gov

3. A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

   This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or immunotherapy) to standard of care therapy alone in treating patients with non-small cell lung cancer (NSCLC) who have remaining lymph node…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Illinois CancerCare - Washington, Washington, Illinois

   Locations

   97 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT07293247 on ClinicalTrials.gov

4. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

   This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Illinois CancerCare - Washington, Washington, Illinois

   Locations

   248 in total

   Run by

   SWOG Cancer Research Network

   See if you can join NCT06116682 on ClinicalTrials.gov

5. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

   This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Illinois CancerCare - Washington, Washington, Illinois

   Locations

   467 in total

   Run by

   Wake Forest University Health Sciences

   See if you can join NCT06418204 on ClinicalTrials.gov